About Amgen
With the accession to the EU in 1995, an Amgen subsidiary was also established in Austria, with headquarters in Vienna. In recent years, several breakthrough drugs have been launched by Amgen in Austria.
These are used for the treatment of the following diseases:
* Side effects of chemotherapies
* Chronic kidney failure
* Rheumatoid arthritis
Amgen continues to work hard to develop innovative medicines in line with the company's goal of "making a difference in patients' lives."
The Austrian subsidiary employs approximately 60 highly qualified employees, a significant number of whom are involved in clinical research.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Focus : Manufacturer
- Industry : Pharma
